On May 27, 2026, Iowa-based seed company Latham Quality filed a federal lawsuit accusing Bayer of illegally monopolizing the U.S. market for genetically modified corn seeds through anti-competitive practices linked to its Roundup-resistant NK603 trait. The case matters because it could reshape the future of the U.S. seed industry and directly impact commodity prices, farm profitability, input costs, agricultural competition, and the U.S. food supply chain at a time when producers are already facing severe economic pressure.

A major federal lawsuit against Bayer is intensifying scrutiny over consolidation in the U.S. agricultural sector and reigniting concerns about how rising seed costs are squeezing American farmers already battling weak margins and volatile commodity markets.

The lawsuit, filed by Iowa-based Latham Quality in the U.S. District Court for the Eastern District of Missouri, accuses Bayer of illegally monopolizing the market for genetically engineered corn seeds resistant to Roundup herbicide. According to the complaint, Bayer used restrictive licensing agreements and aggressive business practices to block competition and maintain control over one of the most widely used biotechnology traits in American agriculture.

The legal challenge comes as the U.S. farm economy faces mounting pressure from elevated input costs, soaring fertilizer prices, expensive fuel, and tightening farm income margins. Farmers across the Corn Belt have entered a fourth consecutive year of declining profitability, increasing political attention on concentration within agricultural supply chains.

Bioinputs

Biologicals Are Not Replacing Agrochemicals: Here's How Leading Farmers Are Using Them

At the center of the dispute is Bayer's NK603 corn trait, a genetically engineered technology designed to tolerate glyphosate-based herbicides such as Roundup. The lawsuit claims that nearly all genetically modified hybrid corn sold in the United States contains the NK603 trait, giving Bayer enormous influence over pricing, licensing, and market access.

According to government estimates cited in the complaint, approximately 92% of U.S. corn acres are planted with herbicide-tolerant seed technologies, making access to these genetics critical for both multinational corporations and independent seed companies.

Latham alleges Bayer continued charging royalties and licensing fees even after the final patent covering NK603 expired in 2022. The lawsuit further claims Bayer prohibited independent companies from developing competing generic alternatives using its genetic seed material, effectively preventing new competition from entering the market.

The complaint describes a highly concentrated seed industry where independent companies struggle to survive against powerful multinational agribusiness corporations. Latham claims Bayer representatives pressured the company to "stay 100% loyal" while retaliating against attempts to develop competing seed products.

According to the filing, Bayer sales representatives allegedly used confidential market information to undermine Latham's business relationships, pushing the family-owned company dangerously close to bankruptcy.

The lawsuit arrives at a politically sensitive moment for the agricultural sector. President Donald Trump's administration has recently emphasized concerns over anti-competitive behavior in food supply chains, crop inputs, and agricultural markets. Last week, the U.S. Department of Justice announced Bayer agreed to remove certain potentially anti-competitive provisions from loyalty programs involving independent seed companies.

The case could become a landmark legal battle over competition in modern agriculture, particularly as consolidation among seed, chemical, and biotechnology companies continues reshaping global food production systems.

Bayer strongly denied the allegations, saying the company competes fairly and complies with all applicable laws. The German agribusiness giant argued that the U.S. corn seed market remains "competitive, fair and diverse."

Still, the lawsuit adds to Bayer's growing legal troubles. The company continues facing thousands of lawsuits alleging Roundup herbicide causes cancer, creating ongoing financial and reputational pressure on its Crop Science division.

Despite the legal uncertainty, Bayer's agricultural business remains highly profitable. In the first quarter of 2026, the company reported a 17.9% increase in Crop Science earnings, reaching approximately 3 billion euros ($3.49 billion).

Agricultural economists and policymakers are now closely watching the case because of its potential impact on seed pricing, farmer choice, agricultural innovation, crop insurance economics, biotechnology licensing, and long-term U.S. food security. If courts determine Bayer unlawfully restricted competition, the outcome could trigger broader reforms in how biotechnology traits are licensed, marketed, and distributed across the American agricultural system.